Binding Molecules For The Treatment Of Myeloid Cell Malignancies

  • Published: Jul 7, 2005
  • Earliest Priority: Jun 25 2003
  • Family: 15
  • Cited Works: 5
  • Cited by: 0
  • Cites: 3
  • Additional Info: Cited Works Full text
Abstract

The present invention provides a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 7, 2005
  • Application: Jun 25, 2004
    WO EP 2004051243 W
  • Priority: Feb 9, 2004
    EP EP 2004050100 W
  • Priority: Jun 25, 2003
    EP EP 0350264 W

Download Citation


Sign in to the Lens

Feedback